Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000869698 | SCV001011145 | likely benign | Familial hypercholesterolemia | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000869698 | SCV001340541 | likely benign | Familial hypercholesterolemia | 2018-07-20 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001805126 | SCV002051368 | likely benign | not specified | 2021-12-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002341197 | SCV002635118 | likely benign | Cardiovascular phenotype | 2015-06-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV004704037 | SCV005209375 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Laboratorium voor Moleculaire Diagnostiek Experimentele Vasculaire Geneeskunde, |
RCV000508930 | SCV000606122 | benign | Hypercholesterolemia, familial, 1 | no assertion criteria provided | research |